Results 81 to 90 of about 13,267 (208)

Advances in the treatment of systemic lupus erythematosus: Biologicals, small‐molecular agents, and cell‐depleting therapies coming to the clinic

Journal of Internal Medicine, EarlyView.
Abstract Systemic lupus erythematosus (SLE; lupus) remains a particular challenge for the practicing clinician on account of its chronic undulating and unpredictable course, its diverse manifestations, and—until recently—limited treatment options all associated with considerable downsides.
Ronald van Vollenhoven
wiley   +1 more source

Mechanical sensitization of sensory afferents after passive transfer of fibromyalgia IgG

The Journal of Physiology, EarlyView.
Abstract figure legend In addition to widespread pain and fatigue, people with fibromyalgia (FM) experience sensory abnormalities and report lingering, painful sensations after touch or mechanical probing of the skin. Administration of IgG purified from FM patients to mice transfers symptoms and signs of FM.
Mathilde R. Israel, Nisha Vastani, Clive Gentry, Andreas Goebel, Stuart Bevan, David A. Andersson   +5 more
wiley   +1 more source

Prevalence of toxic, compression-ischemic, diabetic and atherosclerotic polyneuropathy in teleuts - primary population of Kemerovo region

Acta Biomedica Scientifica, 2013
In the study carried out in primary population of Kemerovo region - teleuts - we determined the prevalence of toxic, compression-ischemic (tunnel), diabetic and atherosclerotic polyneuropathy.
A. V. Osipov, A. V. Kolbasko, A. G. Chechenin, A. L. Onishchenko   +3 more
doaj  

In Vivo Ultrasound Characterization of the Tibial Nerve at the Supramalleolar Region

Journal of Foot and Ankle Research, Volume 19, Issue 3, September 2026.
ABSTRACT Background Accurate knowledge of the supramalleolar anatomy of the tibial nerve is essential for safe ultrasound‐guided procedures and proximal nerve interventions in the foot and ankle. However, quantitative in vivo ultrasound reference data describing its positional anatomy at this level remain scarce.
María Benimeli‐Fenollar, Cecili Macián‐Romero, Lucía Carbonell‐José, María José Chiva‐Miralles, Enrique Sanchis‐Sales, Adrián Jordá‐Vallés, Vicent Tomás‐Martínez   +6 more
wiley   +1 more source

Prevalence of toxic, compression-ischemic, diabetic and atherosclerotic polyneuropathy in primary population of the Kemerovo region - teleuts

Acta Biomedica Scientifica, 2013
In the study based on teleuts population, which are the primary in Kemerovo region, the prevalence of toxic, compression-ischemic, diabetic and atherosclerotic polyneuropathy were determined. It was established, that the frequencies of these diseases are
A. V. Osipov, A. V. Kolbasko, A. G. Chechenin, A. L. Onishchenko   +3 more
doaj  

The Effect of Micronutrient Intake and Supplementation on Prevalent Diabetes‐Related Foot Ulcer and Incident Hospitalisation for Diabetes‐Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2

Journal of Foot and Ankle Research, Volume 19, Issue 3, September 2026.
ABSTRACT Objective To determine whether micronutrient intake and/or supplementation is associated with prevalent diabetes‐related foot ulcer (DFU) and/or incident hospitalisation for DFU in type 2 diabetes. Research Design and Methods Participants with type 2 diabetes from the community‐based Fremantle Diabetes Study Phase II (FDS2; 1499 participants ...
Emma J. Hamilton, Wendy A. Davis, Ranita Siru, Mendel Baba, Timothy M. E. Davis   +4 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8277-8287, September 2026.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source

Use of parenteral vitamin B complexes in treatment of polyneuropathy

Медицинский совет, 2018
The article considers the ethiological factors for the formation of such a widespread disease of the peripheral nervous system as polyneuropathy. The classification, modern approaches to the diagnosis of various types of diseases are presented.
O. V. Kurushina, A. E. Barulin, O. I. Agarkova   +2 more
doaj   +1 more source

Long‐Term Safety and Efficacy of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: ADHERE/ADHERE+ Trial Interim Analysis

Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.
ABSTRACT Background and Aims In ADHERE, subcutaneous efgartigimod PH20 (1000 mg once weekly) was effective and well tolerated in participants with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). ADHERE+ is an open‐label extension of ADHERE assessing long‐term safety and efficacy. Methods Eligible participants from ADHERE run‐in period
Jeffrey A. Allen, Geoffrey Istas, Satoshi Kuwabara, Trevor Mole, Luis Querol, Simon Rinaldi, Mark Stettner, Benjamin Van Hoorick, Richard A. Lewis   +8 more
wiley   +1 more source

Observing nociceptive detection thresholds and evoked potentials in diabetic patients with and without painful neuropathy

Exploration of Neuroscience
Aim: Diabetic polyneuropathy is the most described complication in patients with diabetes mellitus. A significant percentage of these patients experience disabling neuropathic pain (painful diabetic polyneuropathy).
Tom Berfelo, Imre P. Krabbenbos, Boudewijn van den Berg, Silvano R. Gefferie, Jan R. Buitenweg   +4 more
doaj   +1 more source